MJA
MJA

The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022

Md Saiful Islam and Holly Seale
Med J Aust 2024; 221 (8): . || doi: 10.5694/mja2.52453
Published online: 21 October 2024

To the Editor: The findings from Baldwin and colleagues,1 regarding the seroprevalence of Japanese encephalitis virus (JEV)‐specific antibodies in community members (in settings not traditionally considered as risky), underscore the critical need to characterise transmission pathways and identify probable hosts of infection within New South Wales.

Online responses are no longer available. Please refer to our instructions for authors page for more information.